In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries. He discusses XRC’s investment strategy, the criteria it uses to decide which start-up and early stage companies to work with, and the sectors that he sees as ripe for innovation.
Video Forum: Pano Anthos, XRC Ventures
In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Independent Pharmacy Cooperative acquires USave Pharmacy Group
The deal brings together two organizations with a shared commitment to preserving and strengthening independent community pharmacy.
FDA approves Glenmark’s generic Flonase nasal spray
Fluticasone propionate is a corticosteroid used to treat nasal allergy symptoms, including congestion, sneezing, and a runny nose.
Rael gains TowerBrook backing for expansion
The investment will support Rael’s retail expansion, product innovation and global growth.
Yellow Wood Partners to acquire Nestlé's Holistic Health platform
$1.0 billion acquisition comprises VMS leading brands, including Nature's Bounty, the No. 2 VMS brand, and select specialty brands.